Company intelligence / Profile preview

Earlybird Health Technologies

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

Earlybird Health is the healthcare-focused investment arm of Earlybird, a pan-European venture capital firm. Rather than operating as a drug developer, it invests in early-stage to near-commercial healthcare companies across biopharma, medical devices, diagnostics, digital health, and R&D tools. The group positions itself as a specialist healthcare investor supporting portfolio companies from idea to IPO, with operations centered in Germany and investments across Europe. Earlybird Health also highlights a proprietary AI-enabled sourcing and market-intelligence tool called Eagle Eye to identify opportunities and support investment decisions.

Industry: Investors

Partnerships

British Patient CapitalBarmer

Beyond the preview

Go deeper on Earlybird Health Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Earlybird Health Technologies.

Explore the full profile